. Overall survival (OS), disease-specific survival (DSS), recurrencefree survival (RFS) at 5 years, and predictors of survival were determined.
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Melanoma Recurrence after Negative Sentinel lymph Node Biopsy Melinda Davis-Malesevich, MD (presenter); Ryan Goepfert, MD; Jeffrey N. Myers, MD, PhD Objective: Delineate clinico-pathologic factors associated with recurrence of cutaneous melanoma of the head and neck region and survival after negative sentinel lymph node biopsy (SLNB).
Method:
A retrospective review from January 2000 to June 2009 was conducted at a tertiary referral center. Characteristics and outcomes of 204 patients with head and neck melanoma who underwent negative SLNB were analyzed in a univariant and multivariant fashion. Main outcomes measured included: local, regional, distant recurrences, and survival.
Results: A total of 204 patients with cutaneous melanoma of the head and neck underwent successful SLNB, in which final pathology was negative for nodal metastasis. Fifty-nine recurrences occurred in 42 patients: local/in-transit 18, regional 17, and distant metastasis 24. Five recurrences occurred within the same nodal basin that harbored the negative SLN(s). Decreased survival was associated with Breslow thickness (P < .05) and ulceration (P < .006). Local recurrence was associated with Clark level, Breslow thickness, and perineural invasion (P < .05). Regional recurrence was correlated with Breslow thickness (P < .05). Distant metastasis was associated with Breslow thickness, ulceration, nodular histology, and negative SLN(s) located in level V (P < .05). Conclusion: Regional recurrence in a primary echelon nodal basin after negative SLNB is rare (2-4%) and is associated with increased Breslow thickness (>2.0mm). Thus, sentinel node biopsy is highly effective in assessing the draining nodal basin for metasatic disease and for directing further treatment leading to regional disease control.
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Microvascular Free Flaps and intraoperative Vasopressors
Matt Wilson, MD (presenter); Jason P. Hunt, MD; Luke Buchmann, MD Objective: Identify if the use of an intraoperative vasopressor increases the risk of microvascular free flap failure or affects the rate of complications.
Method: A retrospective chart review performed between November 2008 and November 2010 of patients undergoing head and neck microvascular reconstruction. Flap type, ASA classification, use of a vasopressor, and fluid status were documented and analyzed with respect to flap failure and complications. A Fisher exact test was used for statistical analysis.
Results: Eighty-six patients underwent microvascular reconstruction during the study period. No patients were excluded. Seventy-six (88.4%) patients received at least 1 vasopressor intraoperatively. Ten (11.6%) did not have administration of vasopressors. Total flap failure occurred in 3 (3.5%) patients. All flap failures occurred in patients that received vasopressors (3.9%) (P = .696). Flap complications (intraoperative clot requiring revision anastomosis, leech therapy, or flap failure) occurred in 11 (12.8%) patients, including 2 (20%) of the patients that did not receive a vasopressor and 9 (11.8%) of the patients that received a vasopressor (P = .408).
Conclusion:
The use of vasopressors in head and neck microvascular reconstruction is very common. There is no evidence that vasopressors have an effect on microvascular free flap survival or complications. Method: Retrospective study of 46 patients undergoing total thyroidectomy plus prophylactic central lymph node dissection for papillary cancer with preoperative staging T1N0M0 from March 2008 to July 2010. The outcomes were compared with 107 patients in the same conditions and period undergoing total thyroidectomy alone.
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Morbidity of Prophylactic Node Dissection in Thyroid Cancer
Results:
The 2 groups (with and without neck dissection) were similar in age, gender, pathologic features, and completeness
